Original article
Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects
Coenzima Q10 e marcadores pró-inflamatórios em crianças com síndrome de Down: aspectos clínicos e bioquímicos
Moushira E. Zakia, Hala T. El-Bassyounib, Angie M.S. Tossonc,
, Eman Younessd, Jihan Husseind
Corresponding author
a National Research Centre, Medical Research Division, Biological Anthropology Department, Cairo, Egypt
b National Research Centre, Human Genetics and Genome Research Division, Clinical Genetics Department, Cairo, Egypt
c Cairo University, Faculty of Medicine, Pediatrics Department, Cairo, Egypt
d National Research Centre, Medical Research Division, Medical Biochemistry Department, Cairo, Egypt
Read
4344
Timeswas read the article
1829
Total PDF
2515
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 102 | 53 | 155 |
| 2025 11 | 104 | 47 | 151 |
| 2025 10 | 72 | 40 | 112 |
| 2025 9 | 50 | 33 | 83 |
| 2025 8 | 60 | 48 | 108 |
| 2025 7 | 52 | 46 | 98 |
| 2025 6 | 41 | 34 | 75 |
| 2025 5 | 47 | 30 | 77 |
| 2025 4 | 49 | 23 | 72 |
| 2025 3 | 65 | 24 | 89 |
| 2025 2 | 63 | 24 | 87 |
| 2025 1 | 21 | 26 | 47 |
| 2024 12 | 23 | 16 | 39 |
| 2024 11 | 22 | 18 | 40 |
| 2024 10 | 21 | 24 | 45 |
| 2024 9 | 25 | 31 | 56 |
| 2024 8 | 45 | 28 | 73 |
| 2024 7 | 53 | 34 | 87 |
| 2024 6 | 56 | 15 | 71 |
| 2024 5 | 70 | 14 | 84 |
| 2024 4 | 45 | 21 | 66 |
| 2024 3 | 37 | 17 | 54 |
| 2024 2 | 37 | 16 | 53 |
| 2024 1 | 21 | 17 | 38 |
| 2023 12 | 12 | 19 | 31 |
| 2023 11 | 23 | 32 | 55 |
| 2023 10 | 24 | 28 | 52 |
| 2023 9 | 29 | 40 | 69 |
| 2023 8 | 19 | 11 | 30 |
| 2023 7 | 22 | 10 | 32 |
| 2023 6 | 23 | 7 | 30 |
| 2023 5 | 25 | 11 | 36 |
| 2023 4 | 22 | 9 | 31 |
| 2023 3 | 34 | 15 | 49 |
| 2023 2 | 20 | 12 | 32 |
| 2023 1 | 22 | 29 | 51 |
| 2022 12 | 55 | 30 | 85 |
| 2022 11 | 24 | 18 | 42 |
| 2022 10 | 56 | 26 | 82 |
| 2022 9 | 32 | 32 | 64 |
| 2022 8 | 31 | 38 | 69 |
| 2022 7 | 33 | 26 | 59 |
| 2022 6 | 29 | 33 | 62 |
| 2022 5 | 48 | 30 | 78 |
| 2022 4 | 37 | 29 | 66 |
| 2022 3 | 37 | 40 | 77 |
| 2022 2 | 11 | 27 | 38 |
| 2022 1 | 18 | 19 | 37 |
| 2021 12 | 8 | 21 | 29 |
| 2021 11 | 6 | 13 | 19 |
| 2021 10 | 9 | 21 | 30 |
| 2021 9 | 4 | 7 | 11 |
| 2021 8 | 6 | 10 | 16 |
| 2021 7 | 4 | 1 | 5 |
| 2021 6 | 11 | 12 | 23 |
| 2021 5 | 8 | 18 | 26 |
| 2021 4 | 22 | 9 | 31 |
| 2021 3 | 16 | 7 | 23 |
| 2021 2 | 3 | 2 | 5 |
| 2021 1 | 9 | 7 | 16 |
| 2020 12 | 10 | 12 | 22 |
| 2020 11 | 7 | 8 | 15 |
| 2020 10 | 5 | 9 | 14 |
| 2020 9 | 14 | 9 | 23 |
| 2020 8 | 1 | 0 | 1 |
| 2020 7 | 4 | 7 | 11 |
| 2020 6 | 3 | 3 | 6 |
| 2020 5 | 3 | 5 | 8 |
| 2020 4 | 8 | 9 | 17 |
| 2020 3 | 2 | 4 | 6 |
| 2020 2 | 14 | 12 | 26 |
| 2020 1 | 14 | 14 | 28 |
| 2019 12 | 8 | 27 | 35 |
| 2019 11 | 8 | 31 | 39 |
| 2019 10 | 11 | 34 | 45 |
| 2019 9 | 7 | 8 | 15 |
| 2019 8 | 8 | 9 | 17 |
| 2019 7 | 20 | 9 | 29 |
| 2019 6 | 8 | 9 | 17 |
| 2019 5 | 7 | 13 | 20 |
| 2019 4 | 18 | 15 | 33 |
| 2019 3 | 6 | 8 | 14 |
| 2019 2 | 13 | 8 | 21 |
| 2019 1 | 14 | 10 | 24 |
| 2018 12 | 6 | 7 | 13 |
| 2018 11 | 14 | 4 | 18 |
| 2018 10 | 93 | 10 | 103 |
| 2018 9 | 33 | 8 | 41 |
| 2018 8 | 19 | 5 | 24 |
| 2018 7 | 16 | 5 | 21 |
| 2018 6 | 6 | 3 | 9 |
| 2018 5 | 14 | 11 | 25 |
| 2018 4 | 5 | 0 | 5 |
| 2018 3 | 6 | 1 | 7 |
| 2018 2 | 8 | 1 | 9 |
| 2018 1 | 4 | 2 | 6 |
| 2017 12 | 5 | 1 | 6 |
| 2017 11 | 3 | 4 | 7 |
| 2017 10 | 8 | 2 | 10 |
| 2017 9 | 3 | 3 | 6 |
| 2017 8 | 5 | 3 | 8 |
| 2017 7 | 9 | 5 | 14 |
| 2017 6 | 8 | 10 | 18 |
| 2017 5 | 8 | 6 | 14 |
| 2017 4 | 14 | 5 | 19 |
| 2017 3 | 17 | 25 | 42 |
| 2017 2 | 19 | 14 | 33 |
| 2017 1 | 3 | 9 | 12 |
| 2016 12 | 3 | 11 | 14 |
| 2016 11 | 0 | 23 | 23 |
Show all
